Boston Scientific (BSX) Cash & Equivalents Growth (5y) (2014 - 2026)
Powered by 
Analysis
Boston Scientific (BSX) Cash & Equivalents Growth (5y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.86 Bn | 178.25 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 124.18 Bn | 118.97 Bn | 1.96 Bn |
| 3 | Medtronic | 118.18 Bn | 109.36 Bn | 6.34 Bn |
| 4 | Stryker | 104.54 Bn | 101.07 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.34 Bn | 65.80 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.64 Bn | 45.39 Bn | 1.35 Bn |
| 7 | Alcon | 33.93 Bn | 32.47 Bn | 1.68 Bn |
| 8 | Dexcom | 32.20 Bn | 30.25 Bn | 830.00 Mn |
| 9 | Steris | 21.14 Bn | 20.66 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 18.11 Bn | 17.70 Bn | 1.54 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -27.41% |
| Mar 31, 2026 | -6.34% |
| Dec 31, 2025 | 2.53% |
| Sep 30, 2025 | -8.81% |
| Jun 30, 2025 | -20.90% |
| Mar 31, 2025 | 14.40% |
| Dec 31, 2024 | 22.80% |
| Sep 30, 2024 | 29.92% |
| Jun 30, 2024 | 0.63% |
| Mar 31, 2024 | -4.26% |
| Dec 31, 2023 | 42.74% |
| Sep 30, 2023 | -0.58% |
| Jun 30, 2023 | -15.59% |
| Mar 31, 2023 | -13.37% |
| Dec 31, 2022 | 37.62% |
| Sep 30, 2022 | -13.30% |
| Jun 30, 2022 | -10.33% |
| Mar 31, 2022 | -0.12% |
| Dec 31, 2021 | 57.92% |
| Sep 30, 2021 | 52.38% |